Table 3:
Exploratory Endpoints
Total DAOOH through 30 and 90 days post-discharge | Association of B-lines at discharge and 30 and 90 day outcomes |
Change in biomarkers from presentation to pre-discharge | Association of baseline, discharge, and change with 30 and 90 day outcomes |
Time to reach B-lines <15 | B lines < 15 at 24 hours and at discharge |
Composite of 30-day all-cause mortality, cardiovascular (CV) re-hospitalizations, and CV emergency department (ED) revisits. CV endpoints are defined according to the 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events.32 Also for same endpoint, but through 90 days. |
All Cause readmissions, All cause ED revisits |
Change in physical exam findings and body weight from presentation to pre-discharge | Description of ED pharmacologic treatment |
Description of hospital based AHF treatment | Inter and intra-observer agreement |
Trajectory of B-line clearance | Assess B-line clearance by sub-group/HF phenotype |
DAOOH - Days alive and out of hospital